Table 4.
BMPR2, ACVRL1, and SMAD9 gene haplotypes and EH Risk
| Gene | Haplotype | Case (n=460) | Control (n=460) | OR (95% CI) | P value | Adjusted OR (95% CI) | Adjusted P value |
|---|---|---|---|---|---|---|---|
| BMPR2 | CG | 0.215 | 0.523 | 0.249 (0.185–0.336) | <0.001 | 0.468 (0.390–0.557) | <0.001 |
| TT | 0.412 | 0.235 | 2.294 (1.291–1.658) | <0.001 | 1.469 (1.291–1.658) | <0.001 | |
| CT | 0.354 | 0.401 | 0.823 (0.625–1.085) | 0.153 | 0.906 (0.785–1.041) | 0.174 | |
| ACVRL1 | CC | 0.254 | 0.324 | 0.712 (0.529–0.958) | 0.020 | 0.839 (0.712–0.979) | 0.024 |
| SMAD9 | CC | 0.308 | 0.381 | 0.727 (0.548–0.965) | 0.022 | 0.849 (0.730–0.982) | 0.026 |
| TC | 0.326 | 0.343 | 0.925 (0.697–1.228) | 0.576 | 0.961 (0.830–1.106) | 0.625 |
Abbreviations: Acc, accuracy; Bac, balanced; CI, confidence interval; CV, cross-validation; OR, odds ratio.